• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UGCG 通过 B4GalT5 介导的线粒体氧化应激和 ERK 信号通路调节心脏肥大。

UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway.

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Cardiovascular Research Institute, Wuhan University, Wuhan, 430060, China.

出版信息

Cell Mol Biol Lett. 2023 Sep 1;28(1):71. doi: 10.1186/s11658-023-00484-3.

DOI:10.1186/s11658-023-00484-3
PMID:37658291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10472674/
Abstract

Mechanical pressure overload and other stimuli often contribute to heart hypertrophy, a significant factor in the induction of heart failure. The UDP-glucose ceramide glycosyltransferase (UGCG) enzyme plays a crucial role in the metabolism of sphingolipids through the production of glucosylceramide. However, its role in heart hypertrophy remains unknown. In this study, UGCG was induced in response to pressure overload in vivo and phenylephrine stimulation in vitro. Additionally, UGCG downregulation ameliorated cardiomyocyte hypertrophy, improved cardiomyocyte mitochondrial oxidative stress, and reduced the ERK signaling pathway. Conversely, UGCG overexpression in cardiomyocytes promoted heart hypertrophy development, aggravated mitochondrial oxidative stress, and stimulated ERK signaling. Furthermore, the interaction between beta-1,4-galactosyltransferase 5 (B4GalT5), which catalyses the synthesis of lactosylceramide, and UGCG was identified, which also functions as a synergistic molecule of UGCG. Notably, limiting the expression of B4GalT5 impaired the capacity of UGCG to promote myocardial hypertrophy, suggesting that B4GalT5 acts as an intermediary for UGCG. Overall, this study highlights the potential of UGCG as a modulator of heart hypertrophy, rendering it a potential target for combating heart hypertrophy.

摘要

机械压力过载和其他刺激因素常常导致心肌肥厚,这是心力衰竭发生的一个重要因素。UDP-葡萄糖神经酰胺糖基转移酶(UGCG)酶通过产生葡萄糖神经酰胺在神经鞘脂代谢中发挥关键作用。然而,其在心肌肥厚中的作用尚不清楚。在这项研究中,UGCG 在内源性压力过载和苯肾上腺素刺激的体外模型中被诱导。此外,UGCG 的下调改善了心肌细胞肥大,减轻了心肌细胞线粒体氧化应激,并减少了 ERK 信号通路。相反,心肌细胞中 UGCG 的过表达促进了心脏肥大的发展,加重了线粒体氧化应激,并刺激了 ERK 信号。此外,还鉴定出了β-1,4-半乳糖基转移酶 5(B4GalT5)与 UGCG 的相互作用,B4GalT5 催化乳糖神经酰胺的合成,同时也是 UGCG 的协同分子。值得注意的是,限制 B4GalT5 的表达削弱了 UGCG 促进心肌肥大的能力,表明 B4GalT5 作为 UGCG 的中介发挥作用。总的来说,这项研究强调了 UGCG 作为心肌肥厚调节剂的潜力,使其成为对抗心肌肥厚的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/e50114ab28f1/11658_2023_484_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/58b59b7c49df/11658_2023_484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/510fd1701656/11658_2023_484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/7833ee3517b9/11658_2023_484_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/175b4914c829/11658_2023_484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/f64e00c8fd0b/11658_2023_484_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/ee33718fe321/11658_2023_484_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/a031c77b5ad0/11658_2023_484_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/e50114ab28f1/11658_2023_484_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/58b59b7c49df/11658_2023_484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/510fd1701656/11658_2023_484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/7833ee3517b9/11658_2023_484_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/175b4914c829/11658_2023_484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/f64e00c8fd0b/11658_2023_484_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/ee33718fe321/11658_2023_484_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/a031c77b5ad0/11658_2023_484_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c87/10472674/e50114ab28f1/11658_2023_484_Fig8_HTML.jpg

相似文献

1
UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway.UGCG 通过 B4GalT5 介导的线粒体氧化应激和 ERK 信号通路调节心脏肥大。
Cell Mol Biol Lett. 2023 Sep 1;28(1):71. doi: 10.1186/s11658-023-00484-3.
2
Adipocytes harbor a glucosylceramide biosynthesis pathway involved in iNKT cell activation.脂肪细胞中存在参与 iNKT 细胞激活的神经酰胺葡萄糖苷合成途径。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1157-1167. doi: 10.1016/j.bbalip.2019.04.016. Epub 2019 Apr 30.
3
Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides.脂肪甘油三酯脂肪酶的下调通过引发神经酰胺的积累促进心肌细胞肥大。
Arch Biochem Biophys. 2015 Jan 1;565:76-88. doi: 10.1016/j.abb.2014.11.009. Epub 2014 Nov 28.
4
Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells.葡萄糖神经酰胺产量的增加导致非癌细胞的细胞能量代谢降低和肿瘤标志物表达降低。
Cell Mol Life Sci. 2021 Nov;78(21-22):7025-7041. doi: 10.1007/s00018-021-03958-9. Epub 2021 Oct 9.
5
The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1).UDP-葡萄糖神经酰胺糖基转移酶(UGCG)及其与多药耐药蛋白 1(MDR1)的联系。
BMC Cancer. 2018 Feb 6;18(1):153. doi: 10.1186/s12885-018-4084-4.
6
Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.丙泊酚通过血红素加氧酶-1/信号转导和转录激活因子3信号通路改善大鼠高血糖诱导的心脏肥大和功能障碍。
Crit Care Med. 2014 Aug;42(8):e583-94. doi: 10.1097/CCM.0000000000000415.
7
Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.抑制糖脂生物合成通过差异调节慢性髓性白血病中的 ABC 转运蛋白来逆转多药耐药性。
J Biol Chem. 2020 May 8;295(19):6457-6471. doi: 10.1074/jbc.RA120.013090. Epub 2020 Mar 30.
8
UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells.UGCG 过表达导致乳腺癌细胞糖酵解增加和氧化磷酸化增加。
Sci Rep. 2020 May 18;10(1):8182. doi: 10.1038/s41598-020-65182-y.
9
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.miR-142-3p 的过表达改善心肌肥厚中的线粒体功能。
Biomed Pharmacother. 2018 Dec;108:1347-1356. doi: 10.1016/j.biopha.2018.09.146. Epub 2018 Oct 4.
10
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.B 细胞受体通过控制神经酰胺的糖基化来触发原发性 CLL 细胞对药物的敏感性。
Blood. 2012 Nov 8;120(19):3978-85. doi: 10.1182/blood-2012-05-431783. Epub 2012 Aug 27.

引用本文的文献

1
Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants.脂质代谢相关基因在肺移植的体外肺灌注过程中调节免疫微环境。
J Thorac Dis. 2025 Aug 31;17(8):6045-6065. doi: 10.21037/jtd-2025-358. Epub 2025 Aug 27.
2
MiR-491-5p Targets B4GalT5 to Alleviate Airway Inflammation and Remodeling in Asthma by Regulating Pulmonary Oxidative Stress.微小RNA-491-5p通过调控肺部氧化应激靶向β-1,4-半乳糖基转移酶5减轻哮喘气道炎症和重塑
J Inflamm Res. 2025 Aug 25;18:11627-11644. doi: 10.2147/JIR.S544437. eCollection 2025.
3
Heart failure, inflammation and exercise.

本文引用的文献

1
Fibroblast growth factor 5 overexpression ameliorated lipopolysaccharide-induced apoptosis of hepatocytes through regulation of the phosphoinositide-3-kinase/protein kinase B pathway.成纤维细胞生长因子 5 过表达通过调节磷酸肌醇 3-激酶/蛋白激酶 B 通路改善脂多糖诱导的肝细胞凋亡。
Chin Med J (Engl). 2022 Dec 5;135(23):2859-2868. doi: 10.1097/CM9.0000000000002540.
2
Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells.丹酚酸 B 通过抑制肝星状细胞中的神经酰胺葡萄糖基转移酶来抑制肝纤维化。
Acta Pharmacol Sin. 2023 Jun;44(6):1191-1205. doi: 10.1038/s41401-022-01044-9. Epub 2023 Jan 10.
3
心力衰竭、炎症与运动
Int J Biol Sci. 2025 Apr 28;21(8):3324-3350. doi: 10.7150/ijbs.109917. eCollection 2025.
4
B4GALT5 inhibits CD8 T-cell response by downregulating MHC-I level through ERAD pathway in PDAC.B4GALT5通过内质网相关蛋白降解(ERAD)途径下调MHC-I水平,从而抑制胰腺导管腺癌(PDAC)中的CD8 T细胞反应。
J Immunother Cancer. 2025 May 2;13(5):e010908. doi: 10.1136/jitc-2024-010908.
5
Sphingolipid Metabolism and Signalling Pathways in Heart Failure: From Molecular Mechanism to Therapeutic Potential.心力衰竭中的鞘脂代谢与信号通路:从分子机制到治疗潜力
J Inflamm Res. 2025 Apr 23;18:5477-5498. doi: 10.2147/JIR.S515757. eCollection 2025.
6
Advanced Animal Replacement Testing Strategies Using Stem Cell and Organoids.使用干细胞和类器官的先进动物替代测试策略
Int J Stem Cells. 2025 May 30;18(2):107-125. doi: 10.15283/ijsc24118. Epub 2025 Mar 11.
7
Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.米格列司他通过靶向UDP-葡萄糖神经酰胺葡萄糖基转移酶(UGCG)改善异丙肾上腺素诱导的心脏纤维化。
Mol Med. 2025 Feb 11;31(1):55. doi: 10.1186/s10020-025-01093-w.
8
Pharmacology, medical uses, and clinical translational challenges of Saikosaponin A: A review.柴胡皂苷A的药理学、医学用途及临床转化挑战:综述
Heliyon. 2024 Nov 15;10(22):e40427. doi: 10.1016/j.heliyon.2024.e40427. eCollection 2024 Nov 30.
9
Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models.心血管疾病中的糖鞘脂:从分子机制和心力衰竭模型中获得的见解。
Biomolecules. 2024 Oct 8;14(10):1265. doi: 10.3390/biom14101265.
10
IPR1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin.IPR1介导的线粒体相关内质网膜(MAMs)形成促成机械性创伤诱导的肝损伤以及褪黑素的保护作用。
Cell Mol Biol Lett. 2024 Feb 2;29(1):22. doi: 10.1186/s11658-023-00509-x.
ST3GAL5-catalyzed gangliosides inhibit TGF-β-induced epithelial-mesenchymal transition via TβRI degradation.
ST3GAL5 催化的神经节苷脂通过降解 TβRI 抑制 TGF-β 诱导的上皮-间充质转化。
EMBO J. 2023 Jan 16;42(2):e110553. doi: 10.15252/embj.2021110553. Epub 2022 Dec 12.
4
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.靶向 UGCG 克服溶酶体自噬抑制的耐药性。
Cancer Discov. 2023 Feb 6;13(2):454-473. doi: 10.1158/2159-8290.CD-22-0535.
5
SIRT2 promotes cell proliferation and migration through mediating ERK1/2 activation and lactosylceramide accumulation in prostate cancer.SIRT2通过介导ERK1/2激活和乳糖神经酰胺积累促进前列腺癌细胞增殖和迁移。
Prostate. 2023 Jan;83(1):71-81. doi: 10.1002/pros.24437. Epub 2022 Sep 8.
6
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.成纤维细胞 GSK-3α 通过 RAF-MEK-ERK 通路促进损伤心脏的纤维化。
Circ Res. 2022 Sep 16;131(7):620-636. doi: 10.1161/CIRCRESAHA.122.321431. Epub 2022 Sep 2.
7
Selenium alleviates heart remodeling through Sirt1/AKT/GSK-3β pathway.硒通过 Sirt1/AKT/GSK-3β 通路减轻心脏重构。
Int Immunopharmacol. 2022 Oct;111:109158. doi: 10.1016/j.intimp.2022.109158. Epub 2022 Aug 18.
8
METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.METTL3 通过依赖 m6A 的方式加速前 miR-221/222 的成熟来介导 Ang-II 诱导的心肌肥厚。
Cell Mol Biol Lett. 2022 Jul 14;27(1):55. doi: 10.1186/s11658-022-00349-1.
9
Tetrahydrocurcumin improves lipopolysaccharide-induced myocardial dysfunction by inhibiting oxidative stress and inflammation via JNK/ERK signaling pathway regulation.四氢姜黄素通过调节 JNK/ERK 信号通路抑制氧化应激和炎症来改善脂多糖诱导的心肌功能障碍。
Phytomedicine. 2022 Sep;104:154283. doi: 10.1016/j.phymed.2022.154283. Epub 2022 Jun 18.
10
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease.葡萄糖神经酰胺合酶抑制可预防慢性肾脏病中的心肌肥厚。
Sci Rep. 2022 Jun 4;12(1):9340. doi: 10.1038/s41598-022-13390-z.